These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15624270)

  • 21. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
    Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
    Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L
    Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can metformin reduce insulin resistance in polycystic ovary syndrome?
    Açbay O; Gündoğdu S
    Fertil Steril; 1996 May; 65(5):946-9. PubMed ID: 8612854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
    Xing C; Li C; He B
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.
    Velazquez EM; Mendoza SG; Wang P; Glueck CJ
    Metabolism; 1997 Apr; 46(4):454-7. PubMed ID: 9109854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.
    Tiwari N; Pasrija S; Jain S
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():149-154. PubMed ID: 30690191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
    Elter K; Imir G; Durmusoglu F
    Hum Reprod; 2002 Jul; 17(7):1729-37. PubMed ID: 12093831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kouli C; Tsianateli T; Bergiele A
    Eur J Endocrinol; 1998 Mar; 138(3):269-74. PubMed ID: 9539300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels.
    Duleba AJ; Banaszewska B; Spaczynski RZ; Pawelczyk L
    Fertil Steril; 2003 Apr; 79(4):1008-14. PubMed ID: 12749446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial.
    Zheng YH; Wang XH; Lai MH; Yao H; Liu H; Ma HX
    J Altern Complement Med; 2013 Sep; 19(9):740-5. PubMed ID: 23676106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
    Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
    Metabolism; 1999 Apr; 48(4):511-9. PubMed ID: 10206447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
    Underdal MO; Stridsklev S; Oppen IH; Høgetveit K; Andersen MS; Vanky E
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2408-2413. PubMed ID: 29659896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.
    Mishra N; Verma R; Jadaun P
    Cureus; 2022 Jan; 14(1):e21781. PubMed ID: 35251851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.